Translational research of voltage-A1: Efficacy predictors of preoperative chemoradiotherapy and subsequent nivolumab monotherapy in patients with microsatellite-stable locally advanced rectal cancer.

Translational research of voltage-A1: Efficacy predictors of preoperative chemoradiotherapy and subsequent nivolumab monotherapy in patients with microsatellite-stable locally advanced rectal cancer.
复制标题

DOI:
10.1200/jco.2020.38.15_suppl.4073
复制
发表时间:
2020-05
影响因子:
45.3
通讯作者:
K. Inamori;Y. Togashi;H. Bando;Y. Tsukada;A. Suzuki;Yutaka Suzuki;D. Kotani;S. Fukuoka;M. Kojima;M. Fukui;S. Yuki;Y. Komatsu;S. Homma;M. Uemura;Takeshi Kato;Masaaki Ito;H. Nishikawa;T. Yoshino
K. Inamori;Y. Togashi;H. Bando;Y. Tsukada;A. Suzuki;Yutaka Suzuki;D. Kotani;S. Fukuoka;M. Kojima;M. Fukui;S. Yuki;Y. Komatsu;S. Homma;M. Uemura;Takeshi Kato;Masaaki Ito;H. Nishikawa;T. Yoshino
中科院分区:
医学1区
文献类型:
--
作者:
K. Inamori;Y. Togashi;H. Bando;Y. Tsukada;A. Suzuki;Yutaka Suzuki;D. Kotani;S. Fukuoka;M. Kojima;M. Fukui;S. Yuki;Y. Komatsu;S. Homma;M. Uemura;Takeshi Kato;Masaaki Ito;H. Nishikawa;T. Yoshino

文献摘要

相似文献

4073背景:在VOLTAGE-A1中,在5个周期的nivolumab(240 mg q2 weeks)加放化疗后的根治性手术(CRT; 50.4戈伊,卡培他滨1,650 mg/m2)后,主要的病理反应是...
4073Background: In VOLTAGE-A1, after 5 cycles of nivolumab (240 mg q2 weeks) plus radical surgery following chemoradiotherapy (CRT; 50.4 Gy with capecitabine 1,650 mg/m2), a major pathologic respon...